The following table provides an overview of the latest patents of 2seventy Bio, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3689899Nov 24, 2021Mnd Promoter Chimeric Antigen Receptors1
EP3134095Apr 22, 2020Improved Methods For Manufacturing Adoptive Cell Therapies3
EP3134432Dec 25, 2019Mnd Promoter Chimeric Antigen Receptors1